Morgan Stanley T2 Biosystems, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $27,558 - $173 Million	306,202 Added 260.35%	423,813 $48,000
Q2 2022 Oct 27, 2022	SELL	$0.15 - $0.54 $11,131 - $40,073	-74,210 Reduced 38.69%	117,611 $19,000
Q2 2022 Aug 15, 2022	SELL	$0.15 - $0.54 $11,131 - $40,073	-74,210 Reduced 38.69%	117,611 $19,000
Q1 2022 Oct 27, 2022	BUY	$0.36 - $0.57 $26,715 - $42,299	74,210 Added 63.1%	191,821 $101,000
Q1 2022 May 13, 2022	BUY	$0.36 - $0.57 $24,733 - $39,160	68,703 Added 55.8%	191,821 $101,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $20,694 - $42,289	-44,989 Reduced 26.76%	123,118 $64,000
Q3 2021 Nov 15, 2021	BUY	$0.86 - $1.21 $144,572 - $203,409	168,107 New	168,107 $154,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.